Welcome to our dedicated page for VICOR SEC filings (Ticker: VICR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vicor Corporation filings document the operating results, governance, and security structure of a NASDAQ-listed manufacturer of modular power components and complete power systems. Form 8-K reports furnish quarterly and annual financial-results press releases under Item 2.02, with exhibits and Inline XBRL cover data tied to product revenue, royalty revenue, licensing income, and related operating commentary.
Proxy and annual meeting filings cover director elections, executive compensation, equity award tables, pay-versus-performance data, and security-holder voting matters. The filings also describe the company's common stock registered under Section 12(b), the VICR trading symbol, and charter voting rights for Common Stock and Class B Common Stock.
Morgan Stanley Smith Barney LLC filed a Rule 144 resale notice listing Common stock to be sold and documenting multiple 10b5-1 sales by Patrizio Vinciarelli and several institutional holders. The excerpt lists individual sale dates, share counts, and gross proceeds for each trade.
The filing shows repeated 10b5-1 dispositions by Patrizio Vinciarelli across March–June 2026 (multiple 50,000 and other-size trades) and separate smaller sales by Brigham and Women's Hospital and Lahey Hospital & Medical Center. The submission names Morgan Stanley Smith Barney LLC as the broker/agent and lists 20,000 shares in a separate securities block.
Vicor Corp director Estia J. Eichten reported a bona fide gift of 90,000 shares of Common Stock. The shares were gifted at no stated price to a Charitable Remainder Unitrust. After this disposition, the director holds 98,838 shares of Vicor common stock directly.
VICOR CORP Chairman and CEO Patrizio Vinciarelli reported selling 20,000 shares of Vicor common stock. The transactions occurred on June 4, 2026 as multiple open-market sales at prices reported in ranges from about $304.73 to $319.23 per share based on weighted averages.
Following these sales, he holds 8,728,090 shares directly and 167,125 shares indirectly as trustee of the Patrizio Vinciarelli Irrevocable Trust established for the benefit of his child. The filing notes that the sales were effected under a Rule 10b5-1 trading plan, indicating they were pre-arranged rather than discretionary market-timing trades.
VICR Form 144 lists proposed and completed sales of Common Stock by selling holders, many executed under 10b5-1 plans. The filing shows multiple transactions by Patrizio Vinciarelli on dates such as 06/03/2026 (20,000 shares) and 04/16/2026 (40,000 shares). The cover lists shares outstanding as 33,863,689 as of 06/04/2026.
The entries are primarily resale/10b5-1 plan sales executed through Morgan Stanley Smith Barney LLC as broker. Specific per-trade proceeds are shown per line; the filing provides a sequence of routine plan-based dispositions rather than an issuer offering.
Vicor Corporation Chairman and CEO Patrizio Vinciarelli reported open-market sales of 20,000 shares of Vicor common stock on June 3, 2026, across multiple transactions. The sales were executed at weighted average prices within ranges from $323.83 to $339.95 per share. A footnote states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on February 26, 2026. Following these transactions, he directly holds 8,748,090 shares of common stock and indirectly holds 167,125 shares as trustee of an irrevocable trust.
JPMorgan Chase & Co. reports beneficial ownership of 1,556,989 shares of Vicor Corp common stock, representing 4.5% of the class. The filing discloses sole voting power for 1,493,706 shares and sole dispositive power for 1,554,842 shares. The report, signed June 4, 2026, lists several affiliated entities that hold or acquired the securities on behalf of the parent company.
Reported Form 144 sales of common stock by holders including 10b5-1 transactions. The excerpt lists multiple resale entries dated March through June 2026 showing individual sale dates, share counts and dollar amounts. Several rows identify PATRIZIO VINCIARELLI executing recurring 10b5-1 sales of common shares on numerous dates.
Vicor Corp Chairman and CEO Patrizio Vinciarelli reported open-market sales of 20,000 shares of common stock on June 2, 2026 under a pre-arranged Rule 10b5-1 trading plan adopted on February 26, 2026. Sale prices were reported as weighted averages from about $316.63 to $334.59 per share. Following these transactions, he holds 8,768,090 shares directly and 167,125 shares indirectly as trustee of an irrevocable trust.
Insider sales reported for VICR via Form 144 and 10b5-1 plans. The excerpt lists multiple disposition dates and share quantities sold under 10b5-1 instructions by Patrizio Vinciarelli and institutional holders. Examples include 20,000 shares sold on 06/01/2026 for $6,437,096.00 and earlier multi‑day sales in March–April 2026.
The filing itemizes numerous executed sales with corresponding gross proceeds; sale amounts and proceeds are presented per transaction in the excerpt.